JCO Article Insights: LEAP-010 Study in Recurrent/Metastatic Head and Neck Cancer

from Journal of Clinical Oncology (JCO) Podcast

Host Jake New summarizes and offers insights into the JCO article by Licitra et al., "Pembrolizumab With or Without Lenvatinib as First-Line Therapy for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Phase III LEAP-010 Study." LINK TO FULL TRANSCRIPT

Episode metadata supplied by the publisher feed · Published Apr 27, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

JCO Article Insights: LEAP-010 Study in Recurrent/Metastatic Head and Neck Cancer

0:00 10:41

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Journal of Clinical Oncology (JCO) Podcast?

This episode is 10 minutes long.

When was this Journal of Clinical Oncology (JCO) Podcast episode published?

This episode was published on April 27, 2026.

Can I download this Journal of Clinical Oncology (JCO) Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!